Hims & Hers (NYSE: HIMS) CMO awarded 150,489 RSUs over 4 years

Rhea-AI Filing Summary

Carroll Patrick Harrison reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. reported that Chief Medical Officer Patrick Harrison Carroll received a grant of 150,489 Restricted Stock Units. Each RSU represents a contingent right to one share of Class A Common Stock. The award vests over four years in substantially equal quarterly installments on March 15, June 15, September 15 and December 15, beginning on June 15, 2026, subject to continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Carroll Patrick Harrison

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	150,489	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 150,489 shares (Direct)

Footnotes (1)

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carroll Patrick Harrison

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	03/11/2026		A		150,489		(2)	(2)	Class A Common Stock	150,489	$0	150,489	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Patrick Harrison Carroll	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HIMS report for its Chief Medical Officer?

Hims & Hers Health reported that Chief Medical Officer Patrick Harrison Carroll received 150,489 Restricted Stock Units as equity compensation. Each RSU equals one Class A Common share, providing a significant stock-based incentive tied to his continued service at the company.

How many RSUs were granted to the HIMS Chief Medical Officer?

The Chief Medical Officer was granted 150,489 Restricted Stock Units. These RSUs convert into an equal number of Class A Common Stock shares upon vesting, creating a meaningful long-term ownership stake aligned with the company’s future performance and shareholder interests.

What is the vesting schedule for the 150,489 HIMS RSUs?

The 150,489 RSUs vest over four years in substantially equal quarterly installments. Vesting occurs on March 15, June 15, September 15 and December 15, with the first vesting date on June 15, 2026, conditioned on the executive’s continued service.

When do the newly granted HIMS RSUs start vesting?

The first vesting date for the newly granted RSUs is June 15, 2026. After that, additional portions vest on subsequent March 15, June 15, September 15 and December 15 dates, completing the four-year service-based vesting period described in the award terms.

Do the HIMS RSUs involve an immediate cash purchase or sale?

The RSU grant does not involve an immediate market purchase or sale of shares. Instead, it is a stock-based compensation award that converts into Class A Common Stock over time as the service-based vesting requirements are met by the executive.

What does each HIMS Restricted Stock Unit represent?

Each Restricted Stock Unit represents a contingent right to receive one share of Class A Common Stock. Shares are actually delivered only when the RSUs vest, linking the executive’s equity ownership to ongoing employment and the specified multi-year vesting schedule.